Lithium use in octogenarians

被引:5
作者
Fahy, S
Lawlor, BA
机构
[1] St Camillus Hosp, Dept Old Age Psychiat, Limerick, Ireland
[2] Trinity Coll Dublin, Dublin, Ireland
[3] St James Hosp, Dublin 8, Ireland
[4] St Patricks Hosp, Dublin, Ireland
关键词
lithium; octogenarians; thyroid; renal; tolerability;
D O I
10.1002/gps.452
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Objectives To assess the tolerability and side-effect profile of lithium use in a group of octogenarians attending a specialized lithium clinic. Methods This is a cross-sectional study looking at all patients of eighty years and over attending a lithium clinic. Charts were examined to assess renal function, thyroid function and level of side-effects during their course of lithium treatment in order to assess the tolerability of this medication in octogenarians. Results Twelve patients of 80 years and over (with an average age of 83.6 years) were taking lithium for an average period of 53.7 months. They had a mean serum level of 0.42 mmol/l. No patient had to discontinue lithium therapy because of side-effects, even though some patients did develop transient abnormalities of renal function. One patient developed diabetes insipidus. One female patient developed hypothyroidism. Conclusions Lithium was well tolerated and was administered safely to this cohort of octogenarians. Monitoring of serum lithium levels and kidney and thyroid function should preferably be done in the setting of a specialized lithium clinic. Copyright (C) 2001 John Wiley & Sons, Ltd.
引用
收藏
页码:1000 / 1003
页数:4
相关论文
共 17 条
[1]  
Bendz H, 1996, NEPHROL DIAL TRANSPL, V11, P457
[2]   Lithium: balancing risks and benefits [J].
Cookson, J .
BRITISH JOURNAL OF PSYCHIATRY, 1997, 171 :120-124
[3]  
Fielding S, 1999, INT J GERIATR PSYCH, V14, P985
[4]   LITHIUM AUGMENTATION IN THE TREATMENT OF REFRACTORY DEPRESSION IN OLD-AGE [J].
FINCH, EJL ;
KATONA, CLE .
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 1989, 4 (01) :41-46
[5]   CLINICAL RELEVANCE OF DRUG-INTERACTIONS WITH LITHIUM [J].
FINLEY, PR ;
WARNER, MD ;
PEABODY, CA .
CLINICAL PHARMACOKINETICS, 1995, 29 (03) :172-191
[6]   Lithium and the kidney - An updated review [J].
Gitlin, M .
DRUG SAFETY, 1999, 20 (03) :231-243
[7]   LITHIUM PROPHYLAXIS IN RECURRENT AFFECTIVE-ILLNESS - EFFICACY, EFFECTIVENESS AND EFFICIENCY [J].
GUSCOTT, R ;
TAYLOR, L .
BRITISH JOURNAL OF PSYCHIATRY, 1994, 164 :741-746
[8]  
Head L, 1998, INT J GERIATR PSYCH, V13, P164, DOI 10.1002/(SICI)1099-1166(199803)13:3<164::AID-GPS749>3.0.CO
[9]  
2-U
[10]   PLACEBO-CONTROLLED TRIAL OF LITHIUM AUGMENTATION OF FLUOXETINE AND LOFEPRAMINE [J].
KATONA, CLE ;
ABOUSALEH, MT ;
HARRISON, DA ;
NAIRAC, BA ;
EDWARDS, DRL ;
LOCK, T ;
BURNS, RA ;
ROBERTSON, MM .
BRITISH JOURNAL OF PSYCHIATRY, 1995, 166 :80-86